Not provided
Not provided
Not provided
Not provided
Not provided
Lack of patient interest in participating (for adult patients), and lack of parental consent to participate (for pediatric patients)
Not provided
| Name | Class |
|---|---|
| Microsoft Corporation | INDUSTRY |
Not provided
Not provided
The purpose of this study is to to determine how implementing a home-based virtual reality video (VR) game exercise program in young people with Multiple Sclerosis(MS) can improve disability outcomes by measuring its impact on cognitive assessments (BICAMS), subjective measures of cognitive, physical and psychosocial disability, and motor assessments (6MWT).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise Group | Experimental |
| |
| Control Group | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VR active video game intervention | Device | The Microsoft VR active game program will consist of 3 weekly sessions of 45 minutes each combining 3 different types of exercise |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | A measure of sustained attention, working memory and information processing speed. The outcome measure is a numerical score. | 3 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | A measure of sustained attention, working memory and information processing speed. The outcome measure is a numerical score. | 6 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | A measure of sustained attention, working memory and information processing speed. The outcome measure is a numerical score. | 12 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning Test - II (CVLT-II) | A measure of verbal memory (immediate recall) including the first 5 recall trials. The outcome measure is a numerical score (.../80). | 3 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning Test - II (CVLT-II) | A measure of verbal memory (immediate recall) including the first 5 recall trials. The outcome measure is a numerical score (.../80). | 6 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning Test - II (CVLT-II) |
| Measure | Description | Time Frame |
|---|---|---|
| Physical and Psychological Impact of MS as Assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | 29-item self-report measuring the physical and psychological impact of MS from the patient's perspective during the previous 2 weeks. The assessment consists of 29 statements, each scored between 1 (not at all) and 5 (extremely), with a total score between 29 and 145. | 3 Month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephanie Garcia-Tarodo, MD | The University of Texas Health Science Center, Houston | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Texas Health Science Center,Houston | Houston | Texas | 77030 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
The 2 enrolled participants were lost to follow up before they were assigned to an intervention; therefore, no participants "started" per the ClinicalTrials.gov definition of "started," which is "the number of participants assigned to each arm or group."
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | All Participants | The enrolled participants were lost to follow up before being assigned to any intervention. |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Apr 24, 2019 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Educational session | Behavioral | This consists of two education discussion sessions on the benefits of exercise for people with MS. The investigator MS specialists will conduct these sessions either by phone or at the time of a clinic visit and will also discuss difficulties encountered by participants with adherence. |
|
| Standard Management of Physical Activity | Behavioral | Routine discussion of lifestyle factors including physical activity during clinic visits |
|
A measure of verbal memory (immediate recall) including the first 5 recall trials. The outcome measure is a numerical score (.../80). |
| 12 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) - Revised | A measure of visuo-spatial learning and delayed recall, using the first 3 recall trials. The outcome measure is a numerical total score (.../12). | 3 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) - Revised | A measure of visuo-spatial learning and delayed recall, using the first 3 recall trials. The outcome measure is a numerical total score (.../12). | 6 months |
| Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) - Revised | A measure of visuo-spatial learning and delayed recall, using the first 3 recall trials. The outcome measure is a numerical total score (.../12). | 12 months |
| Physical and Psychological Impact of MS as Assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | 29-item self-report measuring the physical and psychological impact of MS from the patient's perspective during the previous 2 weeks. The assessment consists of 29 statements, each scored between 1 (not at all) and 5 (extremely), with a total score between 29 and 145. | 6 month |
| Physical and Psychological Impact of MS as Assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | 29-item self-report measuring the physical and psychological impact of MS from the patient's perspective during the previous 2 weeks. The assessment consists of 29 statements, each scored between 1 (not at all) and 5 (extremely), with a total score between 29 and 145. | 12 month |
| Fatigue as Assessed by the Modified Fatigue Impact Scale (MFIS) | 21-item self-report measuring the impact of fatigue on physical, cognitive and psychosocial aspects of MS during the previous 4 weeks. The assessment contains 21 statements, each scored between 0 (never) and 4 (almost always). Items can be aggregated into three subscales (physical, cognitive, and psychosocial) as well as into a total MFIS score. The physical subscale can range from 0 to 36. The cognitive subscale can range from 0 to 40. The psychosocial subscale can range from 0 to 8. The total MFIS score can range from 0 to 84. | 3 months |
| Fatigue as Assessed by the Modified Fatigue Impact Scale (MFIS) | 21-item self-report measuring the impact of fatigue on physical, cognitive and psychosocial aspects of MS during the previous 4 weeks. The assessment contains 21 statements, each scored between 0 (never) and 4 (almost always). Items can be aggregated into three subscales (physical, cognitive, and psychosocial) as well as into a total MFIS score. The physical subscale can range from 0 to 36. The cognitive subscale can range from 0 to 40. The psychosocial subscale can range from 0 to 8. The total MFIS score can range from 0 to 84. | 6 month |
| Fatigue as Assessed by the Modified Fatigue Impact Scale (MFIS) | 21-item self-report measuring the impact of fatigue on physical, cognitive and psychosocial aspects of MS during the previous 4 weeks. The assessment contains 21 statements, each scored between 0 (never) and 4 (almost always). Items can be aggregated into three subscales (physical, cognitive, and psychosocial) as well as into a total MFIS score. The physical subscale can range from 0 to 36. The cognitive subscale can range from 0 to 40. The psychosocial subscale can range from 0 to 8. The total MFIS score can range from 0 to 84. | 12 month |
| Anxiety and Depression as Assessed by the Hospital Anxiety and Depression Scale (HADS) | 14-item self-report measuring the degree of anxiety and depression in participants during the previous week. The assessment contains 14 statements, each scored between 3 (most of the time) and 0 (not at all). The score can be subdivided into a Depression scale that can range from 0 to 21, and an Anxiety scale, that can range from 0 to 21. | 3 month |
| Anxiety and Depression as Assessed by the Hospital Anxiety and Depression Scale (HADS) | 14-item self-report measuring the degree of anxiety and depression in participants during the previous week. The assessment contains 14 statements, each scored between 3 (most of the time) and 0 (not at all). The score can be subdivided into a Depression scale that can range from 0 to 21, and an Anxiety scale, that can range from 0 to 21. | 6 month |
| Anxiety and Depression as Assessed by the Hospital Anxiety and Depression Scale (HADS) | 14-item self-report measuring the degree of anxiety and depression in participants during the previous week. The assessment contains 14 statements, each scored between 3 (most of the time) and 0 (not at all). The score can be subdivided into a Depression scale that can range from 0 to 21, and an Anxiety scale, that can range from 0 to 21. | 12 month |
| Distance Walked as Assessed by the Six Minute Walk Test (6MWT) | the participant is instructed to walk for six minutes as quickly and safely as possible and the distance covered will be recorded | 6 months |
| Distance Walked as Assessed by the Six Minute Walk Test (6MWT) | the participant is instructed to walk for six minutes as quickly and safely as possible and the distance covered will be recorded | 12 months |
| Number of Clinical Relapses | Assessment at each clinic visit | 12 months |
| New Activity on MRI (T2 Lesions, Gd+) | Assessment at each MRI | 12 months |
| Safety of Implementing a VR Active Video Game Program at Home as Assessed by the Number of Self-reported Incidents That Occur During the Exercise Sessions, Including Falls or Physical Injuries. | 1 month |
| Safety of Implementing a VR Active Video Game Program at Home as Assessed by the Number of Self-reported Incidents That Occur During the Exercise Sessions, Including Falls or Physical Injuries. | 3 month |
| Safety of Implementing a VR Active Video Game Program at Home as Assessed by the Number of Self-reported Incidents That Occur During the Exercise Sessions, Including Falls or Physical Injuries. | 6 month |
| Degree of Incorporation of Physical Activity Into Daily Life as Assessed by a Self Report Questionnaire | 6 months |
| Degree of Incorporation of Physical Activity Into Daily Life as Assessed by a Self Report Questionnaire | 12 months |
| Received an Intervention |
|
| COMPLETED |
|
| NOT COMPLETED |
|
Baseline data were collected before the participants were assigned to an intervention, and the 2 enrolled participants were lost to follow up before they were assigned to an intervention.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All Participants | The enrolled participants were lost to follow up before being assigned to any intervention. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | After searching all records and contacting all team members, the age of one of the participants was not able to be determined. | Mean | Standard Deviation | years |
| ||||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||||
| Race (NIH/OMB) | Count of Participants | Participants |
| ||||||||||||||||||
| Region of Enrollment | Count of Participants | Participants |
| ||||||||||||||||||
| Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | The Brief International Cognitive Assessment for MS (BICAMS) Symbol Digit Modalities Test (SDMT) is a measure of sustained attention, working memory, and information processing speed. It consists of single digits paired with abstract symbols. Participants are asked to voice the digit associated with each symbol as rapidly as possible for 90 seconds. The score is reported as the number correct over the 90-second time span, and possible score ranges from 0 to 120, with a higher score indicating a better outcome. | Mean | Standard Deviation | score on a scale |
| ||||||||||||||||
| Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning test - II | The examiner reads a list of 16 words at a slightly slower rate than one item per second. Participants listen to the list and then report as many of the words as possible. After the first recall, the entire list is read again in the same order followed by a second attempt at recall. Altogether, there are five learning trials. The measure is reported as the total words recalled over trials 1 to 5. Total score ranges from 0 to 80, with a higher score indicating a better outcome. | Mean | Standard Deviation | score on a scale |
| ||||||||||||||||
| Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) | In this test, six abstract designs (in a 2 x 3 array) are presented for 10 seconds. The display is then removed from view and participants are required to draw the 2 x 3 array of figures from memory, with the correct shapes in the correct position. Each design receives from 0 to 2 points representing accuracy and location. There are three learning trials and the outcome measure is the total number of points earned over the three trials. Total score ranges from 0 to 36, with a higher score indicating a better outcome. | Mean | Standard Deviation | score on a scale |
| ||||||||||||||||
| Anxiety and Depression and Indicated by Score on the Hospital Anxiety and Depression Scale (HADS) | Total score ranges from 0 to 42, with a higher score indicating greater anxiety and depression. | Data for this outcome measure were collected from only 1 participant. | Mean | Standard Deviation | score on a scale |
| |||||||||||||||
| Physical and psychological impact of MS as assessed by the Multiple Sclerosis Impact Scale-29 | Total score on the Multiple Sclerosis Impact Scale-29 (MSIS-29) ranges from 29-145, with a higher score indicating a greater impact of multiple sclerosis on day to day life. | Data for this outcome measure were only collected from 1 participant. | Mean | Standard Deviation | score on a scale |
| |||||||||||||||
| Fatigue as assessed by the Modified Fatigue Impact Scale (MFIS) | Total score on the MFIS ranges from 0 to 84, with a higher score indicating greater impact of fatigue on functioning. | Data for this outcome measure were collected for only 1 participant. | Mean | Standard Deviation | score on a scale |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | A measure of sustained attention, working memory and information processing speed. The outcome measure is a numerical score. | Data for this outcome measure were not collected from any participant. | Posted | 3 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | A measure of sustained attention, working memory and information processing speed. The outcome measure is a numerical score. | Data for this outcome measure were not collected from any participant. | Posted | 6 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Symbol Digit Modalities Test (SDMT) | A measure of sustained attention, working memory and information processing speed. The outcome measure is a numerical score. | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning Test - II (CVLT-II) | A measure of verbal memory (immediate recall) including the first 5 recall trials. The outcome measure is a numerical score (.../80). | Data for this outcome measure were not collected from any participant. | Posted | 3 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning Test - II (CVLT-II) | A measure of verbal memory (immediate recall) including the first 5 recall trials. The outcome measure is a numerical score (.../80). | Data for this outcome measure were not collected from any participant. | Posted | 6 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - California Verbal Learning Test - II (CVLT-II) | A measure of verbal memory (immediate recall) including the first 5 recall trials. The outcome measure is a numerical score (.../80). | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) - Revised | A measure of visuo-spatial learning and delayed recall, using the first 3 recall trials. The outcome measure is a numerical total score (.../12). | Data for this outcome measure were not collected from any participant. | Posted | 3 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) - Revised | A measure of visuo-spatial learning and delayed recall, using the first 3 recall trials. The outcome measure is a numerical total score (.../12). | Data for this outcome measure were not collected from any participant. | Posted | 6 months |
|
| ||||||||||||||||||||||
| Primary | Cognitive Disability as Assessed by the Brief International Cognitive Assessment for MS (BICAMS) - Brief Visuospatial Memory Test (BVMT) - Revised | A measure of visuo-spatial learning and delayed recall, using the first 3 recall trials. The outcome measure is a numerical total score (.../12). | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
| ||||||||||||||||||||||
| Secondary | Physical and Psychological Impact of MS as Assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | 29-item self-report measuring the physical and psychological impact of MS from the patient's perspective during the previous 2 weeks. The assessment consists of 29 statements, each scored between 1 (not at all) and 5 (extremely), with a total score between 29 and 145. | Data for this outcome measure were not collected from any participant. | Posted | 3 Month |
|
| ||||||||||||||||||||||
| Secondary | Physical and Psychological Impact of MS as Assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | 29-item self-report measuring the physical and psychological impact of MS from the patient's perspective during the previous 2 weeks. The assessment consists of 29 statements, each scored between 1 (not at all) and 5 (extremely), with a total score between 29 and 145. | Data for this outcome measure were not collected from any participant. | Posted | 6 month |
|
| ||||||||||||||||||||||
| Secondary | Physical and Psychological Impact of MS as Assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29) | 29-item self-report measuring the physical and psychological impact of MS from the patient's perspective during the previous 2 weeks. The assessment consists of 29 statements, each scored between 1 (not at all) and 5 (extremely), with a total score between 29 and 145. | Data for this outcome measure were not collected from any participant. | Posted | 12 month |
|
| ||||||||||||||||||||||
| Secondary | Fatigue as Assessed by the Modified Fatigue Impact Scale (MFIS) | 21-item self-report measuring the impact of fatigue on physical, cognitive and psychosocial aspects of MS during the previous 4 weeks. The assessment contains 21 statements, each scored between 0 (never) and 4 (almost always). Items can be aggregated into three subscales (physical, cognitive, and psychosocial) as well as into a total MFIS score. The physical subscale can range from 0 to 36. The cognitive subscale can range from 0 to 40. The psychosocial subscale can range from 0 to 8. The total MFIS score can range from 0 to 84. | Data for this outcome measure were not collected from any participant. | Posted | 3 months |
| |||||||||||||||||||||||
| Secondary | Fatigue as Assessed by the Modified Fatigue Impact Scale (MFIS) | 21-item self-report measuring the impact of fatigue on physical, cognitive and psychosocial aspects of MS during the previous 4 weeks. The assessment contains 21 statements, each scored between 0 (never) and 4 (almost always). Items can be aggregated into three subscales (physical, cognitive, and psychosocial) as well as into a total MFIS score. The physical subscale can range from 0 to 36. The cognitive subscale can range from 0 to 40. The psychosocial subscale can range from 0 to 8. The total MFIS score can range from 0 to 84. | Data for this outcome measure were not collected from any participant. | Posted | 6 month |
| |||||||||||||||||||||||
| Secondary | Fatigue as Assessed by the Modified Fatigue Impact Scale (MFIS) | 21-item self-report measuring the impact of fatigue on physical, cognitive and psychosocial aspects of MS during the previous 4 weeks. The assessment contains 21 statements, each scored between 0 (never) and 4 (almost always). Items can be aggregated into three subscales (physical, cognitive, and psychosocial) as well as into a total MFIS score. The physical subscale can range from 0 to 36. The cognitive subscale can range from 0 to 40. The psychosocial subscale can range from 0 to 8. The total MFIS score can range from 0 to 84. | Data for this outcome measure were not collected from any participant. | Posted | 12 month |
| |||||||||||||||||||||||
| Secondary | Anxiety and Depression as Assessed by the Hospital Anxiety and Depression Scale (HADS) | 14-item self-report measuring the degree of anxiety and depression in participants during the previous week. The assessment contains 14 statements, each scored between 3 (most of the time) and 0 (not at all). The score can be subdivided into a Depression scale that can range from 0 to 21, and an Anxiety scale, that can range from 0 to 21. | Data for this outcome measure were not collected from any participant. | Posted | 3 month |
|
| ||||||||||||||||||||||
| Secondary | Anxiety and Depression as Assessed by the Hospital Anxiety and Depression Scale (HADS) | 14-item self-report measuring the degree of anxiety and depression in participants during the previous week. The assessment contains 14 statements, each scored between 3 (most of the time) and 0 (not at all). The score can be subdivided into a Depression scale that can range from 0 to 21, and an Anxiety scale, that can range from 0 to 21. | Data for this outcome measure were not collected from any participant. | Posted | 6 month |
|
| ||||||||||||||||||||||
| Secondary | Anxiety and Depression as Assessed by the Hospital Anxiety and Depression Scale (HADS) | 14-item self-report measuring the degree of anxiety and depression in participants during the previous week. The assessment contains 14 statements, each scored between 3 (most of the time) and 0 (not at all). The score can be subdivided into a Depression scale that can range from 0 to 21, and an Anxiety scale, that can range from 0 to 21. | Data for this outcome measure were not collected from any participant. | Posted | 12 month |
|
| ||||||||||||||||||||||
| Secondary | Distance Walked as Assessed by the Six Minute Walk Test (6MWT) | the participant is instructed to walk for six minutes as quickly and safely as possible and the distance covered will be recorded | Data for this outcome measure were not collected from any participant. | Posted | 6 months |
|
| ||||||||||||||||||||||
| Secondary | Distance Walked as Assessed by the Six Minute Walk Test (6MWT) | the participant is instructed to walk for six minutes as quickly and safely as possible and the distance covered will be recorded | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
| ||||||||||||||||||||||
| Secondary | Number of Clinical Relapses | Assessment at each clinic visit | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
| ||||||||||||||||||||||
| Secondary | New Activity on MRI (T2 Lesions, Gd+) | Assessment at each MRI | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
| ||||||||||||||||||||||
| Secondary | Safety of Implementing a VR Active Video Game Program at Home as Assessed by the Number of Self-reported Incidents That Occur During the Exercise Sessions, Including Falls or Physical Injuries. | Data for this outcome measure were not collected from any participant. | Posted | 1 month |
|
| |||||||||||||||||||||||
| Secondary | Safety of Implementing a VR Active Video Game Program at Home as Assessed by the Number of Self-reported Incidents That Occur During the Exercise Sessions, Including Falls or Physical Injuries. | Data for this outcome measure were not collected from any participant. | Posted | 3 month |
|
| |||||||||||||||||||||||
| Secondary | Safety of Implementing a VR Active Video Game Program at Home as Assessed by the Number of Self-reported Incidents That Occur During the Exercise Sessions, Including Falls or Physical Injuries. | Data for this outcome measure were not collected from any participant. | Posted | 6 month |
|
| |||||||||||||||||||||||
| Secondary | Degree of Incorporation of Physical Activity Into Daily Life as Assessed by a Self Report Questionnaire | Data for this outcome measure were not collected from any participant. | Posted | 6 months |
|
| |||||||||||||||||||||||
| Secondary | Degree of Incorporation of Physical Activity Into Daily Life as Assessed by a Self Report Questionnaire | Data for this outcome measure were not collected from any participant. | Posted | 12 months |
|
|
not collected
Both participants were lost to follow up after the time of enrollment, before the intervention was assigned, and before any adverse events could be assessed; therefore, adverse were not monitored or assessed for this study.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | All Participants | The enrolled participants were lost to follow up before being assigned to any intervention. | 0 | 0 | 0 | 0 | 0 | 0 |
Not provided
Not provided
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Rohini D. Samudralwar, MD | The University of Texas Health Science Center at Houston | (832) 325-7077 | Rohini.D.Samudralwar@uth.tmc.edu |
| Jan 13, 2022 |
| Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D060825 | Cognitive Dysfunction |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D001519 | Behavior |
Not provided
Not provided
|
| Native Hawaiian or Other Pacific Islander |
|
| Black or African American |
|
| White |
|
| More than one race |
|
| Unknown or Not Reported |
|
| Participants |
|
| Participants |
|
| Participants |
|
| Units | Counts |
|---|---|
| Participants |
|
| Units | Counts |
|---|---|
| Participants |
|
| Units | Counts |
|---|---|
| Participants |
|
| Participants |
|
| Participants |
|
| Participants |
|